hotspot -WSS

hotspot

author：fashion 2025-09-03 09:20:38 - browse：16314

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Dexcom's push to bring CGM to type 2 diabetes patients

WSS

A letter from the executive editor: The 2023 STATUS List

Hubble vs. James Webb telescope images: See the difference

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Being 'nonadherent' patient made me a more empathetic doctor

Drug cartel violence flares in western Mexico after vigilante leader's killing

For Medicare Advantage, Democrats want stronger protections around AI

hotspot

hotspot

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

How Robert F. Kennedy Jr. distorted vaccine science

Psychedelics group wrestles with new pharma identity

The biotech scorecard for Q3: 15 stock

DIEP, the 'gold standard' of breast reconstruction, is under threat

Key House Republican on health care plans exit from Congress

Alkermes shareholders re

Being 'nonadherent' patient made me a more empathetic doctor

Guidelines to prevent youth baseball injuries need more muscle

For Medicare Advantage, Democrats want stronger protections around AI

knowledge

Beware reading your test results before your doctor does

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Robert F. Kennedy is pitching centrism on health, even on abortion

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

The Readout: Gilead, Bernie Sanders, and other pharma news

Hubble vs. James Webb telescope images: See the difference

hotspot

explore

Wikipedia

explore